Seth Klarman Theravance Biopharma, Inc. Transaction History

Baupost Group LLC

$3.63 Billion
Q2 2024

A detailed history of Seth Klarman (Baupost Group LLC) transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Baupost Group LLC holds 4,200,021 shares of TBPH stock, worth $34.7 Million. This represents 0.98% of its overall portfolio holdings.

Number of Shares

4,200,021

Previous 6,594,126 36.31%

Holding current value

$34.7 Million

Previous $59.1 Million 39.79%

% of portfolio

0.98%

Previous 1.62%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$8.29 - $9.92 $19.8 Million - $23.7 Million	-2,394,105 Reduced 36.31%	4,200,021 $35.6 Million
Q1 2024 May 14, 2024	SELL	$8.22 - $11.59 $6.78 Million - $9.56 Million	-825,100 Reduced 11.12%	6,594,126 $59.1 Million
Q2 2023 Aug 11, 2023	SELL	$10.16 - $11.92 $30.5 Million - $35.8 Million	-3,000,000 Reduced 28.79%	7,419,226 $76.8 Million
Q1 2023 May 12, 2023	SELL	$9.87 - $11.44 $9.87 Million - $11.4 Million	-1,000,000 Reduced 8.76%	10,419,226 $113 Million
Q4 2022 Feb 13, 2023	SELL	$9.65 - $11.34 $19.3 Million - $22.7 Million	-2,000,000 Reduced 14.9%	11,419,226 $128 Million
Q2 2022 Aug 12, 2022	SELL	$8.41 - $10.34 $1.88 Million - $2.32 Million	-224,107 Reduced 1.64%	13,419,226 $122 Million
Q1 2022 May 13, 2022	SELL	$8.33 - $12.96 $140,235 - $218,181	-16,835 Reduced 0.12%	13,643,333 $130 Million
Q3 2021 Nov 12, 2021	BUY	$6.77 - $14.41 $25.4 Million - $54 Million	3,750,000 Added 37.84%	13,660,168 $101 Million
Q2 2021 Aug 13, 2021	BUY	$14.52 - $22.46 $17.1 Million - $26.4 Million	1,175,000 Added 13.45%	9,910,168 $144 Million
Q3 2020 Nov 13, 2020	SELL	$14.79 - $22.49 $8.49 Million - $12.9 Million	-574,000 Reduced 6.17%	8,735,168 $129 Million
Q3 2017 Nov 13, 2017	BUY	$23.88 - $34.96 $222 Million - $325 Million	9,309,168	9,309,168 $319 Million

Others Institutions Holding TBPH

# of Institutions

133

Shares Held

48.6M

Call Options Held

13.9K

Put Options Held

3.1K

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $552M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track Seth Klarman's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baupost Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baupost Group LLC and Seth Klarman with notifications on news.

Account